Skip to main content
Andrea Cercek, MD, Oncology, New York, NY

AndreaCercekMD

Oncology New York, NY

Instructor, Medicine, Weill Cornell Medical College

Overview of Dr. Cercek

Dr. Andrea Cercek is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, New York-Presbyterian Hospital, and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from New York Medical College and has been in practice 13 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 64 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
  • New York Medical College
    New York Medical CollegeClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2006 - 2026
  • CT State Medical License
    CT State Medical License 2024 - 2025
  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Locoregional Therapy plus Systemic Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma—Reply  
    Andrea Cercek, MD, JAMA Oncology
  • Outcomes of Low-Grade Appendiceal Mucinous Neoplasms with Remote Acellular Mucinous Peritoneal Deposits  
    Jinru Shia, Garrett M Nash, Philip B Paty, Andrea Cercek, Campbell S Roxburgh, Annals of Surgical Oncology
  • Pelvic MRI After Induction Chemotherapy and Before Long-Course Chemoradiation Therapy for Rectal Cancer: What Are the Imaging Findings?  
    Andrea Cercek, Leonard Saltz, Marc J Gollub, Patricio Lynn, Martin R Weiser, European Radiology
  • Join now to see all

Lectures

  • Gastrointestinal (Colorectal) Cancer 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Prevalence of germline genetic alterations in colorectal cancer patients. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

  • Locoregional Therapy plus Systemic Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma—ReplyApril 2020

Press Mentions

  • Groundbreaking Clinical Trial Cures Cancer in 100% of Patients
    Groundbreaking Clinical Trial Cures Cancer in 100% of PatientsNovember 20th, 2024
  • Groundbreaking Clinical Trial Achieves 100% Remission Rate for All Cancer Patients
    Groundbreaking Clinical Trial Achieves 100% Remission Rate for All Cancer PatientsOctober 18th, 2024
  • Doctors Reveal 6 Common Signs of Colon Cancer to Look Out for in Young People
    Doctors Reveal 6 Common Signs of Colon Cancer to Look Out for in Young PeopleSeptember 26th, 2024
  • Join now to see all

Other Languages

  • Spanish